Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|November 2, 2025
The Association of Sleep Quality, Sociodemographic, and Disease-Related Factors in Youth Living With Sickle Cell DiseaseTiffany D Tucker, Dakshin S Padmanabhan, Ammar S Alishlash, et al.
Journal of Neurosurgery. Pediatrics|April 4, 2015
Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell diseaseChristoph J Griessenauer, Jeffrey D Lebensburger, Michelle H Chua, et al.
Pediatric Blood & Cancer|December 23, 2011
Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG studyJeffrey D Lebensburger, Scott T Miller, Thomas H Howard, et al.
Blood|December 2, 2011
Hydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectinJeffrey D Lebensburger, Thad Howard, Yunming Hu, et al.
Pediatric Blood & Cancer|December 29, 2022
Pediatric refractory immune thrombocytopenia: A systematic reviewLayan Ibrahim, Selina X Dong, Katie O'Hearn, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney diseaseRobert I Liem, Sophie Lanzkron, Thomas D Coates, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 3, 2020
Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell DiseaseHeidi M Schmidt, Katherine C Wood, Sara E Lewis, et al.
Pediatric Blood & Cancer|March 27, 2015
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 studyMariane De Montalembert, Miguel R Abboud, Anne Fiquet, et al.
Pediatric Blood & Cancer|September 12, 2022
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease centerMonica L Hulbert, Deepa Manwani, Emily Riehm Meier, et al.
Pediatric Blood & Cancer|May 26, 2018
Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthoodJane S Hankins, Jeremie H Estepp, Jason R Hodges, et al.
Pageof 5